Rocket One Inc. Common Stock (NASDAQ:RKTO) Issues Earnings Results

Rocket One Inc. Common Stock (NASDAQ:RKTO) posted its quarterly earnings results on Friday. The company reported ($0.19) earnings per share for the quarter, FiscalAI reports.

Rocket One Inc. Common Stock Trading Down 1.3%

RKTO traded down $0.01 during midday trading on Friday, hitting $0.76. 359,523 shares of the company were exchanged, compared to its average volume of 661,483. The company’s 50 day simple moving average is $0.92 and its 200 day simple moving average is $0.91. The firm has a market capitalization of $17.05 million, a price-to-earnings ratio of -0.95 and a beta of 0.96. Rocket One Inc. Common Stock has a 1-year low of $0.49 and a 1-year high of $2.45.

Institutional Trading of Rocket One Inc. Common Stock

A number of hedge funds have recently added to or reduced their stakes in RKTO. Geode Capital Management LLC grew its holdings in Rocket One Inc. Common Stock by 8.0% in the second quarter. Geode Capital Management LLC now owns 122,575 shares of the company’s stock valued at $143,000 after purchasing an additional 9,071 shares during the period. Lido Advisors LLC acquired a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter worth approximately $32,000. Kestra Private Wealth Services LLC purchased a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter valued at approximately $51,000. Virtu Financial LLC purchased a new position in shares of Rocket One Inc. Common Stock during the 3rd quarter valued at approximately $184,000. Finally, Citadel Advisors LLC acquired a new stake in Rocket One Inc. Common Stock in the 3rd quarter valued at $232,000. 7.08% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on RKTO. Weiss Ratings cut shares of Rocket One Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, August 5th. Wall Street Zen raised Rocket One Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $5.00.

About Rocket One Inc. Common Stock

Hoth Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on the acquisition, licensing and development of novel therapies for dermatological, central nervous system and other debilitating conditions. The company’s strategy emphasizes in-licensing late preclinical or early clinical assets with promising pharmacological profiles and leveraging formulation science to optimize delivery. Core to its approach is the design of topical and localized administration platforms intended to enhance drug penetration, sustain release and reduce systemic exposure.

Hoth’s development pipeline encompasses multiple candidate programs addressing high-unmet-need areas such as atopic dermatitis, epidermolysis bullosa and oral mucositis.